AMAL Therapeutics
Pre-clinicalHarnessing the power of KISIMA® immunisation technology to discover and develop therapeutic vaccines
Founded
2012
Focus
BiologicsVaccines
About
Harnessing the power of KISIMA® immunisation technology to discover and develop therapeutic vaccines
Funding History
5Total raised: $106M
Series B$25MBoehringer Ingelheim Venture FundJun 15, 2019
Series B$53MBoehringer Ingelheim Venture FundJun 15, 2019
Grant$2.5MSwiss Innovation Agency (Innosuisse)Jun 15, 2018
Series A$20MBoehringer Ingelheim Venture FundJun 15, 2017
Company Info
TypePrivate
Founded2012
LocationGeneva, Switzerland
StagePre-clinical
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile